The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

22 Sep 2020 18:30

UPDATE 2-Canada at 'crossroads' with COVID-19 case numbers rising

(Adds flu testing push in Ontario)By Steve SchererOTTAWA, Sept 22 (Reuters) - Canada is facing a surge in COVID-19 cases that risks ballooning to higher levels than were seen during the first wave of the pandemic earlier this year if people do not...

Read more
22 Sep 2020 18:30

UPDATE 1-Canada at 'crossroads' with COVID-19 case numbers rising

(Adds comments, details)By Steve SchererOTTAWA, Sept 22 (Reuters) - Canada is facing a surge in COVID-19 cases that risks ballooning to higher levels than were seen during the first wave of the pandemic in the spring if people do not take stringen...

Read more
22 Sep 2020 18:01

GlaxoSmithKline And Sanofi To Supply Canada With Covid-19 Vaccine

GlaxoSmithKline And Sanofi To Supply Canada With Covid-19 Vaccine

Read more
22 Sep 2020 17:09

Canada warns of rising COVID-19 case numbers, signs new agreements for vaccines

OTTAWA, Sept 22 (Reuters) - Canada is planning for a worst-case scenario in which a new wave of the coronavirus will drive up cases by more than 1,000 per day over the next 10 days, officials said on Tuesday.Canada also announced a new agreement w...

Read more
22 Sep 2020 09:06

UPDATE 2-Coronavirus vaccine makers see EU shield against side-effect claims

(Recasts with industry body on liability)By Francesco GuarascioBRUSSELS, Sept 22 (Reuters) - Vaccine makers will be indemnified in Europe if their COVID-19 shots cause unexpected side-effects, an industry official said on Tuesday, as nearly 40 fir...

Read more
22 Sep 2020 08:48

Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021

Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021

Read more
22 Sep 2020 08:42

LONDON MARKET OPEN: FTSE Bounces Back But Travel Stocks Under Pressure

LONDON MARKET OPEN: FTSE Bounces Back But Travel Stocks Under Pressure

Read more
21 Sep 2020 10:35

Normality could return in summer 2021 if vaccine succeeds - UK health minister

LONDON, Sept 21 (Reuters) - Britain could return to pre-lockdown normal by next summer if a vaccine succeeds and was rolled out in the early part of 2021, health minister Matt Hancock said on Monday, adding that the most vulnerable might be vacci...

Read more
21 Sep 2020 07:51

UPDATE 2-EU agency recommends AstraZeneca-Merck drug Lynparza for two cancers

(Adds context, background on rival treatments)By Aakash B and Pushkala AripakaSept 21 (Reuters) - The European Medicines Agency (EMA) has recommended approval for Lynparza in patients with a form of prostate cancer and as a first-line maintenance t...

Read more
18 Sep 2020 13:47

Positive EU Committee Opinion For GlaxoSmithKline's Zejula

Positive EU Committee Opinion For GlaxoSmithKline's Zejula

Read more
18 Sep 2020 13:13

TOP NEWS: Sanofi, Glaxo Finalise Covid-19 Vaccine Supply Pact With EU

TOP NEWS: Sanofi, Glaxo Finalise Covid-19 Vaccine Supply Pact With EU

Read more
18 Sep 2020 11:55

BRIEF, RPT-Sanofi: confirms EU COVID-19 vaccines deal struck alongside GSK

Sept 18 (Reuters) - (Reporting by Matthias Blamont)

Read more
18 Sep 2020 11:01

EU agrees to purchase Sanofi/GSK Covid-19 vaccine

(Sharecast News) - The European Union agreed an advance purchase agreement with Sanofi and GlaxoSmithKline for the companies' potential Covid-19 vaccine.

Read more
18 Sep 2020 10:51

UPDATE 4-EU pays $384 mln for Sanofi-GSK COVID vaccine as WHO scheme deadline looms

* Sanofi, GSK to supply up to 300 mln shots* EU paid 324 million euros to secure supply* Deal comes on deadline day to join WHO's COVAX scheme* Many wealthy countries still to join (Adds price paid for deal in second paragraph)By Philip Blenkinsop a...

Read more
18 Sep 2020 10:51

UPDATE 3-EU seals second COVID-19 vaccine deal as WHO scheme deadline looms

* Sanofi, GSK to supply up to 300 mln shots* Deal comes on deadline day to join WHO's COVAX scheme* Many wealthy countries still to join (Adds details, context)By Philip Blenkinsop and Matthias BlamontBRUSSELS/PARIS, Sept 18 (Reuters) - The European...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.